nasopharyngeal cancer
Showing 1 - 25 of 49
Gut Microbiota of Critical Chronic Diseases in China
Recruiting
- Essential Hypertension
- +10 more
- no intervention
-
Chaoyang, Beijing, China
- +49 more
Dec 16, 2022
Nasopharyngeal Carcinoma, Nasopharyngeal Cancer Trial in China (Cadonilimab, Gemcitabine, Cisplatin)
Not yet recruiting
- Nasopharyngeal Carcinoma
- Nasopharyngeal Cancer
- Cadonilimab
- +3 more
-
Bengbu, Anhui, China
- +12 more
Dec 13, 2022
Intrinsic Radiation Sensitivity in Cancer Patients
Recruiting
- Nasopharyngeal Cancer
- +2 more
-
Singapore, SingaporeNational Cancer Center Singapore
Dec 1, 2022
Nasopharyngeal Cancer Trial in Shanghai (Toripalimab, Induction chemo and concurrent chemoradiation)
Recruiting
- Nasopharyngeal Cancer
- Toripalimab
- Induction chemotherapy and concurrent chemoradiation
-
Shanghai, Shanghai, ChinaFudan Universtiy Shanghai Cancer Centre
Nov 25, 2022
Breast Cancer, Ovarian Cancer, Non Small Cell Lung Cancer Trial in San Francisco, Denver, San Antonio (P-MUC1C-ALLO1 CAR-T
Recruiting
- Breast Cancer
- +8 more
- P-MUC1C-ALLO1 CAR-T cells
- Rimiducid
-
San Francisco, California
- +4 more
Oct 26, 2022
Nasopharyngeal Cancer, Epstein-Barr Virus Related Carcinoma Trial in Singapore (FDG-PET, Galium-68 DOTATATE)
Recruiting
- Nasopharyngeal Cancer
- Epstein-Barr Virus Related Carcinoma
- FDG-PET
- Galium-68 DOTATATE
-
Singapore, SingaporeNational Cancer Centre Singapore
Oct 13, 2022
Cervical Cancer, Nasopharyngeal Cancer, Chemo-induced Nausea and Vomiting Trial in Shantou (Fosaprepitant, tropisetron,
Recruiting
- Cervical Cancer
- +4 more
- Fosaprepitant
- +2 more
-
Shantou, Guangdong, ChinaCancer Hospital of Shantou University Medical College
Sep 29, 2022
Nasopharyngeal Carcinoma, Nasopharyngeal Cancer Trial in Shanghai (Fluzoparib and Camrelizumab)
Recruiting
- Nasopharyngeal Carcinoma
- Nasopharyngeal Cancer
- Fluzoparib and Camrelizumab
-
Shanghai, Shanghai, ChinaFudan Universtiy Shanghai Cancer Centre
Jun 4, 2022
Nasopharyngeal Cancer, Epstein-Barr Virus Related Carcinoma Trial in Stanford (VK-2019)
Recruiting
- Nasopharyngeal Cancer
- Epstein-Barr Virus Related Carcinoma
-
Stanford, CaliforniaStanford University
Mar 31, 2022
Nasopharyngeal Cancer Trial in Singapore (cisplatin and gemcitabine, induction chemo cisplatin, gemcitabine, bevacizumab and
Not yet recruiting
- Nasopharyngeal Cancer
- cisplatin and gemcitabine
- induction chemotherapy cisplatin, gemcitabine, bevacizumab and pembrolizumab.
-
Singapore, SingaporeNational University Hospital
Mar 22, 2022
Nasopharyngeal Cancer Trial in Jakarta (Auto-Dendritic Adjuvant Therapy, Allo-Dendritic-Secretome Adjuvant Therapy)
Not yet recruiting
- Nasopharyngeal Cancer
- Auto-Dendritic Adjuvant Therapy
- Allo-Dendritic-Secretome Adjuvant Therapy
-
Jakarta, IndonesiaPT Prodia StemCell Indonesia
Mar 1, 2022
Pancreatic Cancer, Thyroid Cancer, Lung Cancer Trial in United States
Recruiting
- Pancreatic Cancer
- +49 more
-
Colorado Springs, Colorado
- +80 more
Feb 22, 2022
Nasopharyngeal Cancer Trial in Hong Kong (Adjuvant chemo (gemcitabine and cisplatin))
Completed
- Nasopharyngeal Cancer
- Adjuvant chemotherapy (gemcitabine and cisplatin)
-
Hong Kong, Hong Kong
- +5 more
Feb 15, 2022
Head Neck Cancer, Head and Neck Tumors, Head and Neck Squamous Cell Carcinoma Trial in Copenhagen (Liquid biopsy)
Recruiting
- Head and Neck Cancer
- +26 more
- Liquid biopsy
-
Copenhagen, Region Hovedstaden, DenmarkUniversity Hospital of Copenhagen, Rigshospitalet
Sep 14, 2021
Nasopharyngeal Cancer, Epstein-Barr Virus Infections Trial in Hong Kong (Recombinant Epstein-Barr Virus (EBV) Vaccine)
Completed
- Nasopharyngeal Cancer
- Epstein-Barr Virus Infections
- Recombinant Epstein-Barr Virus (EBV) Vaccine
-
Hong Kong, Hong KongDepartment of Clinical Oncology, Prince of Wales Hospital
Jul 26, 2021
Xerostomia, Mouth Dryness, Nasopharyngeal Cancer Trial in Shanghai (Acupuncture, Standard Care)
Completed
- Xerostomia
- +2 more
- Acupuncture
- Standard Care
-
Shanghai, ChinaFudan University Cancer Hospital
Jun 8, 2021
Nasopharyngeal Cancer Trial in Guangzhou (Nab paclitaxel)
Recruiting
- Nasopharyngeal Cancer
- Nab paclitaxel
-
Guangzhou, Guangdong, ChinaDepartment of Nasopharyngeal Carcinoma, Sun Yat-sen University C
Apr 22, 2021
Nasopharyngeal Cancer Using Simultaneous 18F-FDG-PET and MRI
Completed
- Nasopharyngeal Cancer
- PET/CT scans
-
New York, New YorkNew York University School of Medicine
Oct 15, 2020
Nasopharyngeal Cancer, Chemo, Radiotherapy Trial in China (Camrelizumab plus chemo-radiotherapy, Chemo-radiotherapy alone)
Recruiting
- Nasopharyngeal Cancer
- +3 more
- Camrelizumab plus chemo-radiotherapy
- Chemo-radiotherapy alone
-
Guangzhou, Guangdong, China
- +5 more
Sep 24, 2020
Nasopharyngeal Cancer, Tumor Metastasis Trial in Hangzhou (radical radiotherapy)
Recruiting
- Nasopharyngeal Cancer
- Neoplasm Metastasis
- radical radiotherapy
-
Hangzhou, Zhejiang, ChinaZhejiang Cancer Hospital
Sep 16, 2020
Liver Cancer, Kidney Cancer, Nasopharyngeal Cancer Trial in Guangzhou (CELL)
Recruiting
- Liver Cancer
- +5 more
- CELL
-
Guangzhou, Guangdong, ChinaSun Yat-sen University Cancer Center
Jul 14, 2020
Hepatocellular Carcinoma (HCC), Cholangiocarcinoma, Esophageal Cancer Trial in Belgium, United States (INCB062079)
Terminated
- Hepatocellular Carcinoma (HCC)
- +5 more
-
Birmingham, Alabama
- +5 more
Jul 13, 2020